Clinigen Group plc (the 'Group', AIM: CLIN) confirms that Martin Abell will join the Group as an executive director and CFO elect with immediate effect.
As announced on 1 April 2015, Robin Sibson, the current CFO, intends to step down and become a non-executive director of the Group. This will happen following a period of handover to Mr Abell after which he will step up as full time CFO.
The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Martin James Abell, aged 41 years, is not currently a director of any other companies but has been a director of the following companies during the five years preceding the date of this announcement:
Hays International Holdings Limited
Hays Temp GmbH
Hays (Schweitz) AG
There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.
Clinigen Group plc
Tel: +44 (0) 1283 495 010
Peter George, Group Chief Executive Officer
Shaun Chilton, Group Deputy CEO
Robin Sibson, Group Chief Financial Officer
Numis Securities Limited
Tel: +44 (0) 20 7260 1000
Michael Meade/Freddie Barnfield (Nominated Adviser)
James Black/Tom Ballard (Corporate Broking)
Peel Hunt LLP - Joint Broker
Tel: +44 (0) 20 7418 8900
James Steel/Jock Maxwell Macdonald
Instinctif Partners - Media Relations
Tel: +44 (0) 20 7457 2020
Melanie Toyne-Sewell/Jayne Crook/Emma Barlow